Stock-Based Compensation
$354.83M
TTM · Period ending: · USD

RPRX Stock-Based Compensation
What is stock-based compensation?
Non-cash compensation expense paid in equity.
RPRX stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | Stock-Based Compensation (USD) | Change |
|---|---|---|
| 289,894,000 | +12,267.49% | |
| 2,344,000 | −0.55% | |
| 2,357,000 | +8.62% | |
| 2,170,000 | −11.17% | |
| 2,443,000 | −54.99% | |
| 5,428,000 | — | |
| 0 | — | |
| 0 | — | |
| 0 | — |
Frequently asked questions: RPRX stock-based compensation
What is Royalty Pharma plc (RPRX)'s current stock-based compensation?
Royalty Pharma plc (RPRX)'s latest reported stock-based compensation (TTM) is $354.83M as of Sep 30, 2026. Non-cash compensation expense paid in equity.
How much historical stock-based compensation data is available for RPRX?
Stock Alarm Pro provides 9 dated annual fiscal periods observations for Royalty Pharma plc (RPRX)'s stock-based compensation, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare RPRX's stock-based compensation to peers or set an alert?
You can open RPRX's stock-based compensation in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on RPRX delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance